Independent validation of the HER2DX genomic test in HER2-positive breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab plus /- pertuzumab (TCH/TCHP): a correlative analysis from a multicenter academic study

Coralia Bueno-Muino,Isabel Echavarria,Sara Lopez-Tarruella, Roche-Molina Marta,Maria Del Monte-Millan,Tatiana Massarrah,Yolanda Jerez Gilarranz,Blanca Herrero,Salvador Gamez,Ivan Marquez-Rodas, Maria Cebollero-Presmanes, Nevado Santos Manuel, Pilar de la Morena Barrio,Francisco Ayala de la Pena,Jose Angel Garcia-Saenz, Fernando Moreno Anton, Alvaro Rodriguez Lescure, Teresa Quintanar, Diego Malon-Gimenez, Laura Rodriguez-Lajusticia, Ana Isabel Ballesteros Garcia, Dulce Banon Torres, Lucia Villarejo,Nerea Lobato, Ainhoa Arias,Inmaculada Ocana,Enrique Alvarez,Laia Pare,Mercedes Marin-Aguilera,Patricia Galvan,Fara Braso-Maristany,Ana Vivancos,Patricia Villagrasa,Joel S. Parker,Charles M. Perou,Aleix Prat,Miguel Martin

CANCER RESEARCH(2023)

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要